Franklin Resources Inc. Has $2.11 Million Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Franklin Resources Inc. lifted its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 99.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,708 shares of the medical instruments supplier's stock after acquiring an additional 5,834 shares during the period. Franklin Resources Inc.'s holdings in ICU Medical were worth $2,111,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Coldstream Capital Management Inc. purchased a new position in shares of ICU Medical during the third quarter valued at $227,000. Geode Capital Management LLC boosted its position in ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after acquiring an additional 48,106 shares during the period. Barclays PLC grew its stake in ICU Medical by 15.6% during the 3rd quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock valued at $10,790,000 after acquiring an additional 8,010 shares in the last quarter. XTX Topco Ltd acquired a new position in shares of ICU Medical in the 3rd quarter valued at about $342,000. Finally, EP Wealth Advisors LLC purchased a new stake in shares of ICU Medical in the third quarter worth approximately $247,000. Institutional investors and hedge funds own 96.10% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ICUI shares. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. KeyCorp increased their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a report on Wednesday, November 13th. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. Finally, Raymond James upped their target price on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a research report on Thursday, September 12th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $199.67.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the company's stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at $18,665,666.78. This represents a 10.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Christian B. Voigtlander sold 1,430 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total value of $225,940.00. The disclosure for this sale can be found here. Insiders have sold 40,364 shares of company stock valued at $6,869,878 over the last three months. 6.70% of the stock is currently owned by insiders.

ICU Medical Stock Down 1.3 %

Shares of ICUI traded down $2.00 during mid-day trading on Friday, hitting $154.46. 133,114 shares of the company's stock were exchanged, compared to its average volume of 270,060. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a twelve month low of $86.80 and a twelve month high of $196.26. The firm has a fifty day moving average of $166.35 and a two-hundred day moving average of $154.35. The stock has a market cap of $3.78 billion, a price-to-earnings ratio of -33.80 and a beta of 0.62.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.